CLSA lifts Lonza Group stock target from CHF 759 to CHF 778

Published on 10/26/2026 at 16:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza confirms 11-12 percent 2026 sales growth on October 14. Lonza Group stock costs EUR 684.10 on October 26, 2026 at 4:15 p.m. CEST.

Analyst target and growth outlook

CLSA raised its Lonza target from CHF 759 to CHF 778 on October 16, 2026.
Lonza confirmed 11-12 percent constant-exchange-rate sales growth for fiscal year 2026 on October 14, 2026.
Lonza Group stock costs EUR 684.10 at Lang & Schwarz on October 26, 2026 at 4:15 p.m. CEST.

Lonza Group, CH0013841017, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) received a higher CLSA price target of CHF 778, up from CHF 759, in a note dated October 16, 2026, as reported by Boerse Express. The stock was trading at EUR 684.10 at Lang & Schwarz on October 26, 2026 at 4:15 p.m. CEST.

Growth targets remain in focus

Lonza confirmed its full-year 2026 outlook on October 14, 2026, including constant-exchange-rate sales growth of 11-12 percent and a CORE EBITDA margin of 33-34 percent. The figures came with the company update on third-quarter performance, which Lonza described as in line with expectations. The official Lonza release also set a medium-term organic sales-growth model of 10-13 percent and a CORE EBITDA margin in the high thirties.

What supports the valuation?

Analyst estimates remain above the current euro quotation, but the currencies differ. CLSA's CHF 778 target cannot be converted into a euro distance here without an evidenced exchange rate. MarketScreener listed 24 analyst estimates, with a median target of CHF 696.61, in its October 14, 2026 coverage of Lonza's investor-day update. The same report described 25 large projects as supporting visibility toward growth through 2030.

Listing and business profile

Lonza is a Swiss contract development and manufacturing organization for pharmaceutical and biotechnology customers. MarketScreener identifies the primary listing as SIX Swiss Exchange under ticker LONN and classifies the company in biotechnology. Its report dated October 14, 2026 also cited Jefferies at CHF 781 and Stifel at CHF 650, while noting that the timing for the medium-term goals was not specified.

Price and investor perspective

The latest euro quotation places the trading reference on the German market at EUR 684.10. The analyst targets are stated in Swiss francs, so the price-level comparison remains separate from the euro quotation. For investors, the key distinction is between Lonza's confirmed fiscal-year 2026 outlook and its longer-term margin ambition.

Lonza Group was trading at EUR 684.10 at Lang & Schwarz on October 26, 2026 at 4:15 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.